Cobenfy (xanomeline and trospium chloride) capsules are the first antipsychotic drug approved to target cholinergic receptors ...

Approval follows EU approval of Dupixent for adults with COPD with raised blood eosinophils, and is based on two landmark Phase 3 trials showing Dupixent significantly reduced exacerbations, improved ...

A research team led by Junior Associate Professor Kazuo Takayama, from the Department of Cell Growth and Differentiation, ...

Learn about magnesium's essential role in overall health and in cancer treatment and prevention. Dr. Urvi Shah answers ...

Noah M. Merin, MD, PhD, assistant professor at Cedars-Sinai Medicine and medical director of the Hematology and Cellular ...

The BRAT diet has long been used to treat stomach bugs, but recent research shows it may not be as helpful as previously ...

The FDA approved dupilumab today as the first biologic treatment for patients with uncontrolled chronic obstructive pulmonary ...

The study demonstrates that treatment with Neurent Medical's NEUROMARK System, a radiofrequency ablation device indicated for chronic rhinitis, led to significant improvements in rhinitis symptoms ...

Dupixent is indicated for the approximately 300,000 adults in the U.S. with inadequately controlled chronic obstructive pulmonary disease (COPD) ...

A new study found that the average frequency of your bowel movements could impact your microbiome and risk of chronic disease ...

The FDA has approved Dupixent as an add-on maintenance treatment for adults with poorly controlled COPD and high counts of ...

The approval was supported by data from the 52-week, randomized, double-blind, multicenter, parallel-group, placebo-controlled, phase 3 trials BOREAS and NOTUS.